CYP1A1 and neoplasm: Contribution of signatures in each cohort is provided on the right; (j–k) Protein abundance of CYP1A1 (j) and AhR (k) in tumor and normal samples within the XWLC cohort; Two-tailed Wilcoxon rank sum test used to calculate p-values in (j–k).